Lyra Therapeutics(LYRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LYRA Lyra Therapeutics

盘前交易 07-22 07:48:38 EDT

0.2800

-0.0089

-3.08%

盘前0.2839

+0.0039+1.39%

06:18 EDT

最高0.2914	最低0.2720	成交量102.52万
今开0.2900	昨收0.2889	日振幅6.72%
总市值1,707万	流通市值1,054万	总股本6,096万
成交额28.51万	换手率2.72%	流通股本3,765万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LYRA","market":"US","secType":"STK","nameCN":"Lyra Therapeutics","latestPrice":0.28,"timestamp":1721419200000,"preClose":0.2889,"halted":0,"volume":1025201,"hourTrading":{"tag":"盘前","latestPrice":0.2839,"preClose":0.28,"latestTime":"06:18 EDT","volume":1,"amount":0.2839,"timestamp":1721643536009},"delay":0,"floatShares":37647458,"shares":60964859,"eps":-1.218237,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0089,"latestTime":"07-22 07:48:38 EDT","open":0.29,"high":0.2914,"low":0.272,"amount":285123.89913912,"amplitude":0.067151,"askPrice":0.3039,"askSize":100,"bidPrice":0.2711,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.218237,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1588305600000,"adjPreClose":0.28,"preHourTrading":{"tag":"盘前","latestPrice":0.2839,"preClose":0.28,"latestTime":"06:18 EDT","volume":1,"amount":0.2839,"timestamp":1721643536009},"postHourTrading":{"tag":"盘后","latestPrice":0.275,"preClose":0.28,"latestTime":"18:39 EDT","volume":7586,"amount":2124.7477,"timestamp":1721428749187},"volumeRatio":0.9089681518978381,"impliedVol":0.6957,"impliedVolPercentile":0.168},"requestUrl":"/m/hq/s/LYRA/wiki","defaultTab":"wiki","newsList":[{"id":"2452663400","title":"Lyra Therapeutics, Inc.盘中异动 股价大跌5.05%报0.274美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452663400","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452663400?lang=zh_cn&edition=full","pubTime":"2024-07-20 02:58","pubTimestamp":1721415524,"startTime":"0","endTime":"0","summary":"北京时间2024年07月20日02时58分，Lyra Therapeutics, Inc.股票出现波动，股价大幅下挫5.05%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407200258449681e976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407200258449681e976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","LYRA","BK4139"],"gpt_icon":0},{"id":"2452455947","title":"Lyra Therapeutics, Inc.盘中异动 下午盘股价大跌5.13%报0.291美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452455947","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452455947?lang=zh_cn&edition=full","pubTime":"2024-07-19 03:16","pubTimestamp":1721330214,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日03时16分，Lyra Therapeutics, Inc.股票出现异动，股价大幅下跌5.13%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.12%。其相关个股中，Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3355.35%、2756.09%、1316.55%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719031654af930212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719031654af930212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2450184950","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.09%报0.285美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450184950","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450184950?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:47","pubTimestamp":1720633625,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日01时47分，Lyra Therapeutics, Inc.股票出现异动，股价大幅拉升5.09%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110147059681b97f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110147059681b97f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYRA","LENZ","BK4007"],"gpt_icon":0},{"id":"2450532021","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450532021","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450532021?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:51","pubTimestamp":1720536676,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时51分，Lyra Therapeutics, Inc.股票出现异动，股价大幅拉升6.54%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225116941f574c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225116941f574c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","LYRA","BK4139"],"gpt_icon":0},{"id":"2448219624","title":"Lyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448219624","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448219624?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:55","pubTimestamp":1719950159,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时55分，Lyra Therapeutics, Inc.股票出现波动，股价大幅跳水5.25%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035559941f32ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035559941f32ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","LYRA"],"gpt_icon":0},{"id":"2448394891","title":"Lyra Therapeutics, Inc.盘中异动 急速拉升5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448394891","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448394891?lang=zh_cn&edition=full","pubTime":"2024-07-02 00:29","pubTimestamp":1719851370,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日00时29分，Lyra Therapeutics, Inc.股票出现异动，股价大幅拉升5.71%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702002930aef770b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702002930aef770b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYRA","LENZ","BK4007"],"gpt_icon":0},{"id":"2446755700","title":"Lyra Therapeutics, Inc.盘中异动 临近午盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446755700","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446755700?lang=zh_cn&edition=full","pubTime":"2024-06-27 23:56","pubTimestamp":1719503798,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日23时56分，Lyra Therapeutics, Inc.股票出现波动，股价急速下跌5.17%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627235638941f1d9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627235638941f1d9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2446902853","title":"Lyra Therapeutics, Inc.盘中异动 大幅拉升5.12%报0.271美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446902853","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446902853?lang=zh_cn&edition=full","pubTime":"2024-06-26 23:15","pubTimestamp":1719414931,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日23时15分，Lyra Therapeutics, Inc.股票出现异动，股价快速上涨5.12%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.57%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626231532968171cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626231532968171cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","LYRA","BK4139"],"gpt_icon":0},{"id":"2444249319","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444249319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444249319?lang=zh_cn&edition=full","pubTime":"2024-06-20 23:52","pubTimestamp":1718898739,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日23时52分，Lyra Therapeutics, Inc.股票出现异动，股价急速拉升5.41%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062023521996815880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062023521996815880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYRA","LENZ","BK4007"],"gpt_icon":0},{"id":"2444192844","title":"Lyra Therapeutics, Inc.盘中异动 股价大跌5.12%报0.280美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444192844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444192844?lang=zh_cn&edition=full","pubTime":"2024-06-18 00:38","pubTimestamp":1718642326,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日00时38分，Lyra Therapeutics, Inc.股票出现异动，股价快速下跌5.12%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618003846af8de645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618003846af8de645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LYRA","LENZ"],"gpt_icon":0},{"id":"2443167561","title":"Lyra Therapeutics, Inc.盘中异动 股价大跌5.55%报0.293美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443167561","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443167561?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:04","pubTimestamp":1718373891,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时04分，Lyra Therapeutics, Inc.股票出现异动，股价大幅下挫5.55%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614220451941eeaca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614220451941eeaca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LYRA","BK4007","BK4139"],"gpt_icon":0},{"id":"2441745365","title":"Lyra Therapeutics, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441745365","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441745365?lang=zh_cn&edition=full","pubTime":"2024-06-06 22:41","pubTimestamp":1717684871,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日22时41分，Lyra Therapeutics, Inc.股票出现波动，股价急速拉升5.16%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606224112aef3d3c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606224112aef3d3c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","LYRA","BK4139"],"gpt_icon":0},{"id":"2437889299","title":"Lyra Therapeutics, Inc.盘中异动 早盘大幅下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437889299","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437889299?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:04","pubTimestamp":1716386659,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时04分，Lyra Therapeutics, Inc.股票出现异动，股价急速下挫5.09%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522220419861ee5d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522220419861ee5d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2435481365","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435481365","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435481365?lang=zh_cn&edition=full","pubTime":"2024-05-14 23:40","pubTimestamp":1715701254,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日23时40分，Lyra Therapeutics, Inc.股票出现波动，股价急速上涨5.57%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142340547a59dbad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142340547a59dbad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2434486375","title":"Lyra Therapeutics, Inc.盘中异动 急速跳水5.38%报0.366美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434486375","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434486375?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:35","pubTimestamp":1715355323,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时35分，Lyra Therapeutics, Inc.股票出现波动，股价急速下跌5.38%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。该信息摘要如下：HC Wainwright & Co.：下调Lyra Therapeutics评级，由买入调整至中性评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102335237a5943c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102335237a5943c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2433552721","title":"Lyra Therapeutics, Inc.盘中异动 股价大跌5.05%报0.399美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433552721","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433552721?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:45","pubTimestamp":1715175924,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时45分，Lyra Therapeutics, Inc.股票出现异动，股价大幅下跌5.05%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。该信息摘要如下：HC Wainwright & Co.：下调Lyra Therapeutics评级，由买入调整至中性评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082145247a58c3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082145247a58c3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","LYRA","BK4139"],"gpt_icon":0},{"id":"2433207646","title":"Lyra Therapeutics, Inc.盘中异动 急速下跌12.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433207646","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433207646?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:31","pubTimestamp":1715088707,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时31分，Lyra Therapeutics, Inc.股票出现波动，股价快速下挫12.48%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721314787dc9dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721314787dc9dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":"    路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻  * 艾睿电子  ：雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc   ：杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc   ：贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc   ：奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc   ：Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","LU0889566641.SGD","CRNX","VERX","NOW","COTY","ARW","BK4204","ACT","CIVI","HWM","LINC","LMND","ACA","LYRA","BOWL","ACHC","PACS","AIG","FRPT","BK4097","BCRX","LU1064131342.USD","PLTR","DSGN","BK4567","ENTA","IART","GOOD","VRTX","GLYC","BECN","MTZ","LITE","ATI","CTO","IR","APA","EVER","CAH","BK4550","CTRA","PNW","HIMS","MCHP","GOSS","FIS","KRC","BV"],"gpt_icon":0},{"id":"2433733284","title":"BUZZ-鼻炎疗法在后期研究中失败，Lyra Therapeutics 大幅下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2433733284","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433733284?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:58","pubTimestamp":1715000323,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月6日 - ** 药物开发商Lyra Therapeutics   股价盘前暴跌91.8%，至32美分 ** 该公司表示，其主要试验性疗法LYR-210没有达到治疗慢性鼻窦炎（一种长期鼻窦炎症）的后期试验的主要目标。 ** LYRA公司称，在24周时，该疗法在改善鼻塞、流鼻涕和面部疼痛等症状方面没有统计学意义。 ** LYRA公司表示，计划对全部数据集进行评估，以确定今后的发展方向。 ** 截至上次收盘，股价累计下跌 23","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYRA","LENZ","BK4139","BUZZ","BK4007"],"gpt_icon":0},{"id":"2432604214","title":"Lyra Therapeutics, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432604214","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432604214?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:47","pubTimestamp":1714657675,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时47分，Lyra Therapeutics, Inc.股票出现异动，股价急速下挫5.33%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221475587e85564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221475587e85564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYRA","BK4007","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lyratherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0378},{"period":"1month","weight":0.0819},{"period":"3month","weight":-0.9461},{"period":"6month","weight":-0.9462},{"period":"1year","weight":-0.9088},{"period":"ytd","weight":-0.9466}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lyra Therapeutics, Inc. 成立于2005年11月21日，是特拉华州的一家公司。LyraTherapeutics，Inc.是一家临床阶段的治疗公司，致力于针对耳部患者的局部治疗的新型集成药物和递送解决方案的开发和商业化 ，鼻和喉（“ ENT”）疾病。 该公司的专有技术平台XTreo旨在通过一次给药就可以持续地将药物直接准确，持续地直接输送到受影响的组织。 该公司的最初产品候选产品LYR-210和LYR-220是可生物吸收的聚合物基质，旨在通过简短，无创的办公室内程序进行给药，旨在为鼻窦通道提供长达六个月的连续药物治疗 用于治疗慢性鼻鼻窦炎（“ CRS”）。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.089692},{"month":2,"riseRate":0.75,"avgChangeRate":0.148346},{"month":3,"riseRate":0.25,"avgChangeRate":-0.09267},{"month":4,"riseRate":0.5,"avgChangeRate":0.074484},{"month":5,"riseRate":0.25,"avgChangeRate":-0.301422},{"month":6,"riseRate":0.6,"avgChangeRate":0.066367},{"month":7,"riseRate":0.6,"avgChangeRate":-0.014459},{"month":8,"riseRate":0.5,"avgChangeRate":0.014239},{"month":9,"riseRate":0.5,"avgChangeRate":0.030528},{"month":10,"riseRate":0,"avgChangeRate":-0.136782},{"month":11,"riseRate":0.5,"avgChangeRate":-0.052313},{"month":12,"riseRate":0.25,"avgChangeRate":0.043528}],"exchange":"NASDAQ","name":"Lyra Therapeutics","nameEN":"Lyra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lyra Therapeutics(LYRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lyra Therapeutics(LYRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lyra Therapeutics,LYRA,Lyra Therapeutics股票,Lyra Therapeutics股票老虎,Lyra Therapeutics股票老虎国际,Lyra Therapeutics行情,Lyra Therapeutics股票行情,Lyra Therapeutics股价,Lyra Therapeutics股市,Lyra Therapeutics股票价格,Lyra Therapeutics股票交易,Lyra Therapeutics股票购买,Lyra Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lyra Therapeutics(LYRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lyra Therapeutics(LYRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}